Post-earnings recap
Reported
Wed, Apr 22, 2026
EPS actual
$3.36
EPS est.
$3.37
EPS surprise
-0.39%
1-day move
+0.46%
CME Group's earnings report shows a slight miss on EPS, but the stock reacted positively, gaining 0.46%. This suggests that investors may be encouraged by management's focus on operational efficiency and their ability to navigate market volatility. The lack of guidance may leave some investors uncertain about future performance, but the stock's uptick indicates a level of confidence in the company's strategy.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.36 | N/A | -0.39% |
Management expressed cautious optimism about navigating current market challenges. They noted the importance of operational efficiency in maintaining performance.
Management highlighted ongoing market volatility as a key factor in performance.
They emphasized their commitment to maintaining operational efficiency.
Future growth will depend on market conditions and client engagement.
CME Group Inc. is a leading financial exchange that facilitates trading in various asset classes, including commodities, derivatives, and financial products. As a major player in the financial sector, CME Group plays a crucial role in price discovery and risk management for market participants globally.
Last quarter
In the last quarter, CME Group reported an EPS of $2.77, slightly beating estimates. The stock experienced a modest increase following the earnings report, indicating a positive market reaction.
EPS beat streak
1Q
EPS beat rate
75%
Avg EPS surprise
+0.58%
Avg 1-day reaction
+1.03%
Overall expectations for CME's upcoming earnings are cautious, given the lack of analyst estimates and management guidance. Investors will be closely watching for any signs of growth or challenges in trading volumes.
Bull case
If CME reports strong trading volumes and beats EPS estimates, it could signal robust market activity and investor confidence, potentially driving the stock higher.
Bear case
Conversely, if trading volumes decline or EPS falls short of expectations, it may raise concerns about market demand and competitive pressures, leading to a negative reaction.
The print will turn on these.
Q1
What was the trading volume for Q1-2026?
Trading volume is a critical metric that directly impacts CME's revenue and profitability, making it a focal point for investor sentiment.
Q2
How does CME plan to address competitive pressures in the financial exchanges market?
Understanding CME's strategy in a competitive landscape will help investors gauge its future growth potential and market positioning.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Why consensus could be wrong
The market may be underestimating the potential for CME to capture increased trading activity in volatile market conditions, which could lead to stronger-than-expected results.
Supporting evidence
CME has consistently beaten EPS estimates in the past, suggesting a potential for continued strong performance.
The options market is pricing a larger move than historical averages, indicating heightened expectations.
Recent trends in financial markets may drive increased trading volumes, benefiting CME.
Key risk
If trading volumes exceed expectations significantly, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around CME's ability to maintain or grow its trading volumes amid competitive pressures and market conditions.
Bull confirmed if
A trading volume increase of over 10% year-over-year would confirm the bull case.
Bear confirmed if
A decline in trading volume or a significant miss on EPS would confirm the bear case.
What the market is pricing for the move.
Implied Move
±3.18%
Historical Avg
±1.5%
The options market is pricing in a significant move of approximately 3.18%, indicating that traders anticipate volatility around the earnings report.
Options are pricing ±3.2% while CME has averaged ±1.5% over the last 8 prints — setup is pricing rich.
30d HV
25.3%
Open-market trades by officers, directors, and 10%+ holders over the trailing 90 days.
Bought
$78,625.74
292.55 sh
1 insider
Sold
$0.00
0 sh
0 insiders
Net
$78,625.74
Net buying
Most Active Insiders· 1 open-market trade
Smart-money positioning from the most recent 13F filings.
Institutional
91.90%
of float
Insider
0.44%
of float
Holders
2,319
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
30,566,342 sh · $8.3B
8.50%
-2.8%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If CME beats expectations, history suggests the stock could see a modest increase of around 0.04% on the following day, confirming positive market sentiment.
In line / cautious
An in-line report could lead to cautious trading, with investors focusing on management's commentary about future growth prospects.
Miss
If CME misses expectations, the stock could decline, with historical patterns indicating an average drop of around 0.44%.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
0 buys·1 sell
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
$78,625.74
Net buying
Recent Transactions
Sep 25, 2026 · @ $268.76
292.55 sh
$78,625.74
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.
Vanguard Capital Management LLC
23,661,856 sh · $6.4B
6.58%
1.3%
State Street Corporation
16,346,170 sh · $4.4B
4.55%
1.8%
Morgan Stanley
9,728,195 sh · $2.6B
2.71%
3.4%
Geode Capital Management, LLC
9,271,309 sh · $2.5B
2.58%
1.4%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Jun 16, 2026 · disclosed Jul 2, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.